Document is current

Article History

First Online: 24 April 2021

DISCLOSURES

: Y.Y.J. has received research funding from Rgenix, Boehringer Ingelheim, Bayer, Genentech/Roche, Bristol-Myers Squibb, Eli Lilly, and Merck and served on advisory boards for Rgenix, Merck Serono, Bristol-Myers Squibb, Eli Lilly, Pfizer, Bayer, Imugene, Merck, Daiichi-Sankyo, and AstraZeneca. G.Y.K. has received honoraria and research funding from Merck, Bristol-Myers Squibb, and Pieris, and research funding from AstraZeneca, Zymeworks, and Daiichi Sankyo. D.H.I. has received research funding from and served on advisory boards for Astellas, Eli Lilly, Pieris, and Taiho, and served on advisory boards for Astra-Zeneca, Amgen, Bayer, Bristol-Myers Squibb, and Roche. S.B.M. has received research funding from Genentech and Guardant Health and served on advisory boards for Natera and Basileahas. All disclosed funding was provided to the institution for other studies. All other authors declare that they have no financial relationships to disclose. This research was supported in part by the NIH/NCI Cancer Center Support Grant P30 CA008748.